Comparing Telmisartan Amlodipine FDC vs. Telmisartan Cilnidipine FDC in Indian Hypertensive Patients: Latest START RENAL 2026 Update Deeksha Bhandari1 July 2026 12:45 PM ISTA recently published study has shown that the fixed-dose combination (FDC) of telmisartan-amlodipine showed significantly better blood pressure (BP)...
Dapagliflozin Metformin in T2D: Six Potential Benefits Beyond Glucose Lowering-Dr Setu Gupta Dr Setu Gupta1 July 2026 12:20 PM ISTWhile dapagliflozin-metformin dual fixed-dose combinations (FDCs) are increasingly used in type 2 diabetes (T2D) management, their complementary...
Merck Marks Beta Blocker Month: Revisiting a Landmark Discovery & Spotlight on Bisoprolol Deeksha Bhandari30 Jun 2026 11:57 AM ISTMerck is commemorating Beta Blocker Month in June by celebrating the discovery of beta-blockers, their lasting impact on cardiovascular care, and...
CKM Syndrome Stage 1: Why Obesity Is No Longer a Cosmetic Problem Dr Kartikeya Kohli26 Jun 2026 11:00 AM ISTUSA: The 2026 AHA/ACC/ADA/ASN Guideline on Cardiovascular-Kidney-Metabolic (CKM) Syndrome presents a new framework that views obesity, diabetes,...
Dapagliflozin in Heart Failure: Cardiologist's Practical Perspective Dr. Bhumika Maikhuri25 Jun 2026 10:15 AM ISTHeart failure (HF) affects an estimated 64.3 million people globally and approximately 8-10 million individuals in India, where it remains a major...
Managing CKM Stage 2: The Critical Window to Prevent Heart and Kidney Disease Dr. Bhumika Maikhuri22 Jun 2026 9:00 AM ISTIn the newly released 2026 AHA/ACC/ADA/ASN Guideline on Cardiovascular-Kidney-Metabolic (CKM) Syndrome, Stage 2 represents a turning point in the...
Managing CKM Stage 4: When Cardiovascular Disease Becomes Clinical Dr. Bhumika Maikhuri20 Jun 2026 11:15 AM ISTThe 2026 AHA/ACC/ADA/ASN Guideline on Cardiovascular-Kidney-Metabolic (CKM) Syndrome introduces a powerful truth: A heart attack is not the beginning...
Dapagliflozin & Kidney: Top 5 New Evidence Highlights in 2026 Dr. Bhumika Maikhuri19 Jun 2026 10:30 AM ISTChronic kidney disease (CKD) is among the most common and serious complications of type 2 diabetes (T2D), affecting nearly 32% of Indian patients...
Oral Sun Protection in Melasma, Acne, and PIH: Clinical Needs and Considerations- Dr Ravindra Babu P Dr Ravindra Babu Paruchuri19 Jun 2026 10:15 AM ISTPigmentary disorders represent a significant dermatological burden in India. Acne affects 66.6% of the population, while melasma (50.2%) and...
From Obesity to Heart Failure: Understanding the New CKM Staging System Dr. Bhumika Maikhuri19 Jun 2026 10:15 AM ISTFor decades, medicine has treated obesity, diabetes, kidney disease, and heart disease as separate conditions. A patient would visit one specialist...
Managing CKM Stage 3: Detecting Silent Cardiovascular Disease Before It Becomes a Heart Attack Dr. Bhumika Maikhuri19 Jun 2026 9:00 AM ISTThe newly released 2026 AHA/ACC/ADA/ASN Guideline on Cardiovascular-Kidney-Metabolic (CKM) Syndrome introduces a powerful concept in preventive...
Safety and Effectiveness of Vedolizumab in Indian Patients with Inflammatory Bowel Disease: Results from a Phase 4 Study Deeksha Bhandari18 Jun 2026 12:19 PM ISTVedolizumab showed an acceptable safety profile and clinical effectiveness in Indian patients with moderate-to-severe inflammatory bowel disease...
